The size of the Breast Imaging Market in the Asia Pacific region was worth USD 0.52 Billion in 2019 and is Projected to Reach USD 0.83 Billion by 2024, to grow at a CAGR of 9.86% during the forecast period 2019 - 2024.
The significant factors that are boosting the growth of Asia Pacific Breast Imaging Technologies Market are enhancements in breast imaging modalities, growing awareness and government initiatives are leading to advancements in healthcare, increasing incidence of breast cancer, escalation of research & developments in breast cancer therapies, Launch of innovative products by healthcare companies which are offering comfort for the women undergoing screening.
Certain limitations are opposing the growth of the Asia Pacific breast imaging market. They are, the high cost of breast imaging systems and budget restrictions, healthcare facilities are hesitant to invest in new or technologically high-end systems, patients may face psychological health issues due to radiation exposure, restrictions by regulatory bodies, expensive installation and maintenance costs.
Developing economies of the Asia Pacific countries like India, Japan, China, Australia, South Korea, and remaining countries, are expected to provide opportunities for the growth of the Asia Pacific Breast imaging market. Due to increasing healthcare expenditures in Japan resulting in product and service portfolio expansion, which is likely to fuel the growth of the Breast Imaging market in the region, it will impact the growth of the Asia Pacific market during the forecast period.
An increase in private and government investments for the development of innovative and advanced breast imaging technologies due to growing demand for breast cancer screenings, drawbacks of existing imaging systems and psychological effects that are associated with overdiagnosis, are likely to increase growth opportunities.
Also, changes in reimbursement policies, the evolution of advanced imaging systems like nuclear imaging, ultrasound, MRI, near infra-red optical imaging, bioelectric imaging, are the factors anticipated to advance the growth opportunities for the Asia Pacific Breast imaging market.
Asia Pacific Breast Imaging Market segmented and sub-segmented into the following categories.
Asia Pacific is expected to register the highest CAGR in the coming years. Acquisitions and new product development endeavors in the growing economies of India and China are expected to further boost the growth of the breast imaging market over the forecast period. Moreover, factors such as improvements in the healthcare infrastructure, the rising investment, and the multi-national industrial growth within this region along with the increase in the number of government initiatives to raise awareness are driving the market growth in this region.
Some of the Promising Companies leading the Asia Pacific Breast Imaging Market Profiled in the Report are Hologic, Inc., GE Healthcare, Siemens Healthcare, Philips Healthcare, Fujifilm Holdings Corporation Gamma Medica, Inc., Toshiba Corporation, Sonocine, Inc., Aurora Imaging Technology, Inc., and Dilon Technologies, Inc.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type
5.1.1 Introduction
5.1.2 Ionizing Technologies
5.1.2.1 Mammography
5.1.2.2 Digital Mammography
5.1.2.3 3D Mammography
5.1.2.4 Molecular Breast-Specific Gamma Imaging (MBI/BSGI)
5.1.2.5 Positron Emission Tomography and Computed Tomography (PET-CT)
5.1.2.6 Cone-Beam Computed Tomography (CBCT)
5.1.2.7 Positron Emission Mammography (PEM)
5.1.3 Non-ionizing Technologies
5.1.3.1 Breast MRI
5.1.3.2 Breast Ultrasound
5.1.3.3 Automated Whole-Breast Ultrasound (AWBU)
5.1.3.4 Breast Thermography
5.1.3.5 Optical Imaging
5.1.4 Y-o-Y Growth Analysis, By Type
5.1.5 Market Attractiveness Analysis, By Type
5.1.6 Market Share Analysis, By Type
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Type
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Type
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Type
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Hologic Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 GE Healthcare
8.3 Siemens Healthcare
8.4 Philips Healthcare
8.5 Fujifilm Holdings Corporation Gamma Medica Inc.
8.6 Toshiba Corporation
8.7 Sonocine Inc.
8.8 Aurora Imaging Technolog Inc.,
8.9 Dilon Technologies, Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
